These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 28063904
1. A rational approach towards development of amorphous solid dispersions: Experimental and computational techniques. Chakravarty P, Lubach JW, Hau J, Nagapudi K. Int J Pharm; 2017 Mar 15; 519(1-2):44-57. PubMed ID: 28063904 [Abstract] [Full Text] [Related]
2. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions. Tian Y, Booth J, Meehan E, Jones DS, Li S, Andrews GP. Mol Pharm; 2013 Jan 07; 10(1):236-48. PubMed ID: 23110477 [Abstract] [Full Text] [Related]
3. Investigation of Phase Mixing in Amorphous Solid Dispersions of AMG 517 in HPMC-AS Using DSC, Solid-State NMR, and Solution Calorimetry. Calahan JL, Azali SC, Munson EJ, Nagapudi K. Mol Pharm; 2015 Nov 02; 12(11):4115-23. PubMed ID: 26457879 [Abstract] [Full Text] [Related]
4. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems. Tian Y, Jones DS, Andrews GP. Mol Pharm; 2015 Apr 06; 12(4):1180-92. PubMed ID: 25692314 [Abstract] [Full Text] [Related]
5. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Marsac PJ, Shamblin SL, Taylor LS. Pharm Res; 2006 Oct 06; 23(10):2417-26. PubMed ID: 16933098 [Abstract] [Full Text] [Related]
6. Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions. Dalsania S, Sharma J, Munjal B, Bansal AK. Pharm Res; 2018 Jan 09; 35(2):29. PubMed ID: 29368174 [Abstract] [Full Text] [Related]
7. Application of Thermodynamic Phase Diagrams and Gibbs Free Energy of Mixing for Screening of Polymers for Their Use in Amorphous Solid Dispersion Formulation of a Non-Glass-Forming Drug. Mamidi HK, Rohera BD. J Pharm Sci; 2021 Jul 09; 110(7):2703-2717. PubMed ID: 33609521 [Abstract] [Full Text] [Related]
8. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction. Chen Y, Wang S, Wang S, Liu C, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F. Pharm Res; 2016 Oct 09; 33(10):2445-58. PubMed ID: 27283830 [Abstract] [Full Text] [Related]
9. Molecular modeling as a predictive tool for the development of solid dispersions. Maniruzzaman M, Pang J, Morgan DJ, Douroumis D. Mol Pharm; 2015 Apr 06; 12(4):1040-9. PubMed ID: 25734898 [Abstract] [Full Text] [Related]
10. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium. Baghel S, Cathcart H, O'Reilly NJ. Eur J Pharm Biopharm; 2016 Oct 06; 107():16-31. PubMed ID: 27378287 [Abstract] [Full Text] [Related]